Rural hospitals have long struggled to stay afloat. But now, the sector is facing a wave of closings under additional financial pressures, some caused by the pandemic that has strained resources.
The West Lafayette life sciences company was awarded the $974,349 grant to further the development of a core technology known as Collymer. It can be used to create implantable materials for tissue restoration and reconstruction needs such as breast tissue, skeletal muscle, cartilage and more.
The medical-device maker is vigorously defending itself against a mountain of lawsuits that claim its inferior vena cava (IVC) filters, designed to catch blood clots, are unsafe.
The FDA has agreed to speed up review of donanemab, but the Centers for Medicare and Medicaid Services is moving to limit reimbursement for drugs in this class to only patients in clinical trials.
Tremain has been president of the Indiana Donor Network since 2012, and coaxes people at every opportunity to consider donating their organs after they die to others who need a kidney, liver, heart or other organ.
Indiana’s life-sciences sector, often hailed as a key driver of the state’s economy, landed a record $433 million in venture funding last year, despite the COVID-19 pandemic that challenged so many other sectors, from restaurants to airlines.
Originally intended to divert low-level, nonviolent offenders from criminal justice apparatus, the AIC has assessed 1,700 residents for struggles with mental health or substance abuse disorders.
Not only do you have to rearrange plans to visit customers or attend conferences, but you suddenly need to isolate in a hotel room, find restaurants that deliver, and perhaps reschedule flight and hotel plans.
Central Indiana hospitals diverted ambulances for nearly 3,000 hours during a six-week period this fall, according to information IBJ received from the Indiana State Department of Health through an open-records request.
For the past year, Indiana employers have faced the challenge of whether to enforce COVID-19 vaccination mandates on workers who say the vaccines violate their religious beliefs.
The partners are on the prowl to buy hundreds of primary care medical practices.
In Indiana last year, dozens of insurers across the state rolled out plans hoping to get a sizable piece of the fast-growing market.
Indiana University Health, the state’s largest hospital system, recently hired 700 traveling nurses to work in its 16 hospitals under 13-week contracts.
Fast-growing software company Greenlight Guru recently moved into new, bigger office space at the Union Campus on South Meridian Street. The company says it is committed to maintaining physical offices, even as its remote workforce grows.
People needing a COVID-19 test for travel, work or school are spending hours, sometimes days, looking for a place that can squeeze them in and turn around results quickly.
According to a report by the Indiana Economic Development Corp., the Hoosier state ranks second nationally for worldwide life sciences exports and among the top five states for life sciences industry jobs.
The sectors in central Indiana account for one out of every 10 jobs here, or 164,144 workers, and the jobs pay an average of $77,229, according to the report commissioned by BioCrossroads.
The clock is ticking for workers at large hospital systems across central Indiana to get vaccinated for COVID-19 or risk losing their jobs.
Indianapolis’ newest publicly company, Point Biopharma Inc., is the latest player in a field expected to see explosive growth as doctors and researchers look for new ways to shrink tumors.
Gil Peri, a 6-foot, 8-1/2-inch, gregarious administrator with an easy laugh, started his job on June 28, after spending about four years as president and chief operating officer at Connecticut Children’s Medical Center.
